Form 8-K - Current report:
SEC Accession No. 0001104659-25-066451
Filing Date
2025-07-08
Accepted
2025-07-08 17:07:44
Documents
12
Period of Report
2025-07-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520110d_8k.htm   iXBRL 8-K 25223
  Complete submission text file 0001104659-25-066451.txt   188766

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20250703.xsd EX-101.SCH 3023
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20250703_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20250703_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2520110d_8k_htm.xml XML 3644
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 251111643
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)